1 completed, 1 enrolling by invitation. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Enrolling by invitation 1 |
| Phase 2 | 1 | Completed 1 |
Follow Plasminogen Deficiency, Type I: new trials by email Literature Review of Plasminogen Deficiency, Type I trials Research Report on Plasminogen Deficiency, Type I
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis Allogenic plasma aliquots, a source of plasminogen - Ligneous Conjunctivitis, Left Eye | Phase 3 | Enrolling by invitation | Dorothy Bautista, MD | 1 | 2025-05-01 | 2024-11-22 |
| Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients Human Plasminogen - Ligneous Conjunctivitis | Phase 2 / Phase 3 | Completed | Kedrion S.p.A. | 12 | 2013-05-22 | 2023-01-25 |
Congenital Plasminogen Deficiency (1)
Plasminogen (1)
Dorothy Bautista, MD (1) · Kedrion S.p.A. (1)
Canada (1) · Italy (1) · United States (1)